Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hata, Tomoko
365  Ergebnisse:
Personensuche X
?
1

Clinical impact and characteristics of erythroid dysplasia ..:

Maeda, Tomoya ; Matsuda, Akira ; Kanda, Junya...
British Journal of Haematology.  204 (2024)  5 - p. 2086-2096 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Development and evaluation of a rapid one-step high sensiti..:

Hidaka, Michihiro ; Inokuchi, Koiti ; Uoshima, Nobuhiko...
Japanese Journal of Clinical Oncology.  54 (2023)  2 - p. 153-159 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Dasatinib-based 2-step induction for adults with Philadelph..:

Sugiura, Isamu ; Doki, Noriko ; Hata, Tomoko...
Blood Advances.  6 (2022)  2 - p. 624-636 , 2022
Link: https://doi.org/10.1182/..
 
?
4

ASXL1 mutations with serum EPO levels predict poor response..:

Morita, Yasuyoshi ; Nannya, Yasuhito ; Ichikawa, Motoshi...
International Journal of Hematology.  116 (2022)  5 - p. 659-668 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Alvocidib inhibits IRF4 expression via super‐enhancer suppr..:

Sakamoto, Hikaru ; Ando, Koji ; Imaizumi, Yoshitaka...
Cancer Science.  113 (2022)  12 - p. 4092-4103 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Prospective comparison of 5- and 7-day administration of az..:

Miyazaki, Yasushi ; Kiguchi, Toru ; Sato, Shinya...
International Journal of Hematology.  116 (2022)  2 - p. 228-238 , 2022
Link: https://doi.org/10.1007/..
 
?
7

A phase II randomized study evaluating azacitidine versus c..:

Iida, Hiroatsu ; Imada, Kazunori ; Ueda, Yasunori...
International Journal of Hematology.  115 (2022)  5 - p. 694-703 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Allogeneic hematopoietic stem cell transplantation for adul..:

Sakamoto, Hikaru ; Itonaga, Hidehiro ; Sawayama, Yasushi...
International Journal of Hematology.  113 (2021)  5 - p. 765-769 , 2021
Link: https://doi.org/10.1007/..
 
?
9

Gilteritinib versus chemotherapy in Japanese patients with ..:

Hosono, Naoko ; Yokoyama, Hisayuki ; Aotsuka, Nobuyuki...
International Journal of Clinical Oncology.  26 (2021)  11 - p. 2131-2141 , 2021
Link: https://doi.org/10.1007/..
 
?
10

The response-guided ATG treatment provides a survival benef..:

Fujioka, Machiko ; Itonaga, Hidehiro ; Furumoto, Takafumi...
Transplant Immunology.  67 (2021)  - p. 101417 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Correction to: Programmed death 1 ligand (PD-L1) in solid c..:

Kasai, Sachie ; Itonaga, Hidehiro ; Niino, Daisuke...
International Journal of Hematology.  112 (2020)  6 - p. 906-906 , 2020
Link: https://doi.org/10.1007/..
 
?
12

Phase 1b/2 study of blinatumomab in Japanese adults with re..:

Kiyoi, Hitoshi ; Morris, Joan D. ; Oh, Iekuni...
Cancer Science.  111 (2020)  4 - p. 1314-1323 , 2020
Link: https://doi.org/10.1111/..
 
?
13

Treatment with mogamulizumab or lenalidomide for relapsed a..:

Sakamoto, Hikaru ; Itonaga, Hidehiro ; Sawayama, Yasushi...
Hematological Oncology.  38 (2020)  2 - p. 162-170 , 2020
Link: https://doi.org/10.1002/..
 
?
14

Programmed death 1 ligand (PD-L1) in solid cancers after al..:

Kasai, Sachie ; Itonaga, Hidehiro ; Niino, Daisuke...
International Journal of Hematology.  112 (2020)  4 - p. 524-534 , 2020
Link: https://doi.org/10.1007/..
 
?
15

No clear survival benefit of azacitidine for lower‐risk mye..:

Toriyama, Eo ; Hata, Tomoko ; Yokota, Ken‐ichi...
Cancer Science.  111 (2020)  12 - p. 4490-4499 , 2020
Link: https://doi.org/10.1111/..
 
1-15